PSY24 COST OF CARE FOR CHRONIC MYELOID LEUKEMIA (CML) IN PATIENTS EXPERIENCING RESISTANCE AND/OR INTOLERANCE TO IMATINIB FROM THE PUBLIC HEALTH SYSTEM PERSPECTIVE IN MEXICO
Abstract
Authors
G Hernndez-Rivera Aguayo O Cantu-Rodrguez E Cervera D Gomez-Almaguer H Gutirrez M Lopez-Hernndez D Martnez P Oropeza E Rico BM Donato A Juarez-Garcia J Vargas-Valencia